Call for nuclear medicine residents in training: EANM congress 2024
Format of this session : The ‘expert’ will provide an introductory talk of 15-20 minutes to describe the state of the art referring to existing guidelines. Then, a team of nuclear medicine residents will challenge the expert with questions on this topic supported by real life data, clinical cases or local experience.
4 Grants : All recipients will receive a complementary EANM congress registration and €1000 travel allowance.
Eligibility criteria :
- Nuclear medicine resident in training (3rd, 4th or 5th year).
- Member of BELNUC
- Submit a personal statement/motivation letter.
- Submit an interesting and unpublished image with a 150-word abstract.
- Submission deadline : Wednesday 15 May 2024 12:00 CET. Application should be sent to firstname.lastname@example.org
Selection procedure :
All applicants are invited to present their case on June 1st after the Belnuc seminar (details will follow later).
Results will be announced by the Belnuc president by email mid June 2024.
BELNUC LinkedIn account
The BELNUC Association has now upped their Social Media presence by creating a BELNUC LinkedIn account.
Take a look at our LinkedIn profile to keep yourself up-to-date and enjoy some interaction within the BELNUC community!
BELNUC 2024 Membership renewal available!
The renewal for the BELNUC 2024 Membership is now available on the myBELNUC platform!
Further information regarding the membership like membership types, membership fees or advantages of being a BELNUC member can be found on our BELNUC Membership page.
Login to your myBELNUC account and renew your membership today to continue to benefit from your BELNUC membership!
BELNUC General Assembly and Seminar: February 24th, 2024
Save the date for the next annual BELNUC General Assembly and Seminar: 24/02/2024 at the KUL campus (9:00 – 12:30).
- Venue: KUL Leuven, Code Parking 7655#, auditorium GA1 located at Onderwijs & Navorsing 1.
The annual BELNUC General Assembly and Seminar is kindly supported by Von Gahlen.
Von Gahlen is a state-of-the-art manufacturer of shielding solutions for nuclear medicine and radiopharmacy. We offer standard and custom-built hot cells along with a wide range of auxiliary equipment for hot labs. With Von Gahlen you can be assured of safe solutions, a reliable partnership, and a lasting relationship.
Seminar topic: PET in hematological Malignancies:
The last fifteen years have been marked by the harmonization of interim and end-of-treatment PET/CT interpretation criteria in lymphoma (Deauville scale 2009).
Nowadays, the implementation of PET/CT guided therapeutic strategies and the development of new prognostic biomarkers on baseline PET/CT, such as total metabolic tumor volume and tumor dissemination metrics are necessary.
It is time to propose standardized measurements of metabolic tumor burden to prepare for risk adaptation in lymphoma.
Likewise, the implications of PET imaging in multiple myeloma for treatment and response assessment will also be detailed.
Moderators: Dr Anne Delcourt Mouscron and Pr Olivier Gheysens UCL Bruxelles
09:00-09:45 Marie Vercruyssen – Hematology HUB
“Lymphoma and Multiple Myeloma in 2024: PET guided management and new treatments”
09:45-10:30 Pr. Andrea Gallamini – from Nice.
“New metrics of PET scan reading in lymphoma”
11:00-11:30 Pr. Nadia Withofs – CHU Liège.
“Guideline on the use of PET/CT in Multiple Myeloma”
11:30-12:30 General assembly
- RIZIV/INAMI has granted 2 credits (Category 3, N°23032711) – RIZIV/INAMI accreditation for nuclear medicine physicians is available for BELNUC members only.
- FANC/AFCN has granted: 2h pour les médecins nucléaristes, 2h pour les personnes habilitées en médecine nucléair, 2h pour les radiophysiciens en médecine nucléair, 2h pour les radiopharmaciens
Open call for BELNUC Tech Board members
The BELNUC Tech Board is urgently looking for technologists (preferably French speaking) that want to join their enthusiastic team and help shape the future of BELNUC activities.
Are you willing to contribute fresh ideas and assist in the Tech Board activities? Send in your application today using the form below!
NMN Symposium: Diagnostic and Therapeutic Innovations in the Era of Precision Medicine – Nuclear Medicine Meets Neuro-Oncology
NMN Symposium: Precision Medicine
April 26-27th, 2024 in Vienna, Austria
We would like to inform you that the registration to the first Symposium on „Diagnostic and Therapeutic Innovations in the Era of Precision Medicine – Nuclear Medicine Meets Neuro-Oncology“ to be held on April 26-27th 2024 in Vienna is now open.
You can find all information including the program on our website.
Please note that you can also sign up for our newsletter to receive updates as we approach the meeting.
Open call BELNUC Board members 2024
During the 2024 General Assembly (24/02/2024), the BELNUC members will elect a new board:
– position of President-elect.
– position of General Secretary-elect.
– one regular board members will be open.
– one member position for a physicist will be open.
If you are interested, applications can now be submitted until 7/01/2024!
Slides from Seminar (September 2023)
Slides from BELNUC Seminar (September 2023)
Moderators: Vanessa Schelfhout and Sophie Bourgeois
|09:00 – 09:30
Glioblastoma work-up and collaboration with the nuclear medicine department.
|09:30 – 10:00
Use of 18F-FET-PET/CT and 68Ga-Dotatate-PET/CT in the management of brain tumors: practical use and pitfalls.
|10:00 – 10:30
|10:30 – 11:00
Use of 177Lu-NeoB for therapy of glioblastoma.
|11:00 – 12:15
|Extraordinary General assembly with M. Marcelis (Notaris)
2021 General Assembly and Cardiology Seminar – Registration Open!
Registration for the 2021 General Assembly and Cardiology Seminar, taking place on March 06, 2021 is now open.
BELNUC Membership 2021
BELNUC membership renewal 2021 is now possible!
Attention: As BELNUC is using a new database, your “old” username and password are not valid anymore.
Please be aware that all member-accounts of the previous 2 years have been transferred into our new membership-database. Everybody who has been transferred to the new database has received a link on February 04, 2021. If you have not received a personalized email regarding your login-data you may create a new account.
If you have any questions, please feel free to contact email@example.com